Diabetes and orthopaedic surgery: a review

• Published in: Orthopaedics and trauma Vol. 33; no. 4; pp. 212 - 216
• Main Authors: Kumar, Vishwajeet, Patel, Bhavik Y., Robinson, Andrew HN
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.08.2019
• Subjects: diabetes mellitus; immunology; orthopaedic surgery; outcomes; pathophysiology; perioperative management; orthopaedic surgery; diabetes mellitus; perioperative management; outcomes; immunology; pathophysiology
• ISSN: 1877-1327; 1877-1335
• DOI: 10.1016/j.mporth.2019.05.002

Diabetes mellitus (DM) is common, estimated to affect 425 million people worldwide in 2017. It is a condition that is continually growing in prevalence and is often associated with multiple co-morbidities. Its multi-system effects on the body mean that its management can pose a challenge, even to more experienced clinicians. In orthopaedic practice, diabetic patients are commonly encountered owing to their increased fracture risk and complications of the disease such as diabetic foot. An appropriate knowledge of diabetes, its pathophysiology, immunology and the pharmacology of medications used in its treatment is essential, as the consequences of mismanagement can be grave. Optimal treatment of diabetics can often require the involvement of a wider multidisciplinary team. Complications that can be encountered in the perioperative and postoperative periods include, diabetic ketoacidosis, hyperosmolar hyperglycaemic state, surgical site infection and venous thromboembolism. This review outlines current concepts in the perioperative management of diabetes and its manifestations within orthopaedic surgery, with a focus on outcomes and complications. A review of the available literature reveals conflicting conclusions between studies, with no clear effect or consensus yet established for many issues. There is a need for a greater number of well-designed, high-quality, appropriately powered trials to establish the true effect of diabetes on outcomes in orthopaedic surgery.